APA

Sedky M. S., Hamouda A., Taha H., Zaky I., Hassanain O., El Hemaly A. & ElHaddad A. (20200414). Outcome of High-risk Langerhans Cell Histiocytosis (LCH) in Egyptian Children, Does Intermediate-dose Methotrexate Improve the Outcome?. : Journal of pediatric hematology/oncology.

Chicago

Sedky Mohamed S, Hamouda Asmaa, Taha Hala, Zaky Iman, Hassanain Omayma, El Hemaly Ahmed and ElHaddad Alaa. 20200414. Outcome of High-risk Langerhans Cell Histiocytosis (LCH) in Egyptian Children, Does Intermediate-dose Methotrexate Improve the Outcome?. : Journal of pediatric hematology/oncology.

Harvard

Sedky M. S., Hamouda A., Taha H., Zaky I., Hassanain O., El Hemaly A. and ElHaddad A. (20200414). Outcome of High-risk Langerhans Cell Histiocytosis (LCH) in Egyptian Children, Does Intermediate-dose Methotrexate Improve the Outcome?. : Journal of pediatric hematology/oncology.

MLA

Sedky Mohamed S, Hamouda Asmaa, Taha Hala, Zaky Iman, Hassanain Omayma, El Hemaly Ahmed and ElHaddad Alaa. Outcome of High-risk Langerhans Cell Histiocytosis (LCH) in Egyptian Children, Does Intermediate-dose Methotrexate Improve the Outcome?. : Journal of pediatric hematology/oncology. 20200414.